R&D The value of unstructured data for drug companies Advancements in medical AI now allow pharmaceutical companies to leverage unstructured clinical data at scale.
Digital Implementing generative AI: A guide for commercial life scie... In a market saturated with articles highlighting the potential of generative AI, it’s crucial to also understand its limitations.
Digital Smarter learning and better outcomes: How AI can provide an ... AI is revolutionising medical education, optimising learner outcomes and, ultimately, improving real-world patient care.
Sales & Marketing Compliance baked into the design core: On AI in life science... In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Florian Schnappauf, VP, enterprise commercial strategy Europe, at Veeva Systems.
Digital Sovereign AI as the backbone of LSHC GCC innovation: Priorit... In recent times, Global Capability Centres (GCCs) have become drivers of innovation for global Life Sciences and Healthcare (LSHC) companies.
News CHMP decision levels the playing field for GSK's RSV jab GSK's RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and Moderna.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
